{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:40:18Z","timestamp":1786120818598,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370765"],"award-info":[{"award-number":["32370765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01228-z","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T14:04:33Z","timestamp":1779977073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of limb-bud and heart (LBH) drives liver cancer progression by interacting with the oncoprotein Mortalin"],"prefix":"10.1007","volume":"49","author":[{"given":"Xingqi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"1228_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"A. Vogel, T. Meyer, G. Sapisochin, R. Salem, A. Saborowski, Hepatocellular carcinoma. Lancet. 400, 1345\u20131362 (2022)","journal-title":"Lancet"},{"key":"1228_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram, A. Jemal, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024)","journal-title":"CA Cancer J. Clin."},{"key":"1228_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Y. Wang, B. Deng, Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 42, 629\u2013652 (2023)","journal-title":"Cancer Metastasis Rev."},{"key":"1228_CR4","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep4.1823","volume":"5","author":"N Adeniji","year":"2021","unstructured":"N. Adeniji, R. Dhanasekaran, Current and Emerging Tools for Hepatocellular Carcinoma Surveillance. Hepatol. Commun. 5, 1972\u20131986 (2021)","journal-title":"Hepatol. Commun."},{"key":"1228_CR5","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","volume":"28","author":"AX Zhu","year":"2022","unstructured":"A.X. Zhu, A.R. Abbas, de M.R. Galarreta, Y. Guan, S. Lu, H. Koeppen, W. Zhang, C.H. Hsu, A.R. He, B.Y. Ryoo et al., Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nat. Med. 28, 1599\u20131611 (2022)","journal-title":"Nat. Med."},{"key":"1228_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/dbio.2001.0225","volume":"233","author":"KJ Briegel","year":"2001","unstructured":"K.J. Briegel, A.L. Joyner, Identification and characterization of Lbh, a novel conserved nuclear protein expressed during early limb and heart development. Dev. Biol. 233, 291\u2013304 (2001)","journal-title":"Dev. Biol."},{"key":"1228_CR7","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1242\/dev.01887","volume":"132","author":"KJ Briegel","year":"2005","unstructured":"K.J. Briegel, H.S. Baldwin, J.A. Epstein, A.L. Joyner, Congenital heart disease reminiscent of partial trisomy 2p syndrome in mice transgenic for the transcription factor Lbh. Development. 132, 3305\u20133316 (2005)","journal-title":"Development"},{"key":"1228_CR8","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s11010-021-04111-7","volume":"476","author":"A Wu","year":"2021","unstructured":"A. Wu, L. Zhang, J. Chen, H. Li, P. Yang, M. Chen, Q. Liu, Limb-bud and Heart (LBH) mediates proliferation, fibroblast-to-myofibroblast transition and EMT-like processes in cardiac fibroblasts. Mol. Cell. Biochem. 476, 2685\u20132701 (2021)","journal-title":"Mol. Cell. Biochem."},{"key":"1228_CR9","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.4049\/jimmunol.1700719","volume":"199","author":"S Matsuda","year":"2017","unstructured":"S. Matsuda, D. Hammaker, K. Topolewski, K.J. Briegel, D.L. Boyle, S. Dowdy, W. Wang, G.S. Firestein, Regulation of the Cell Cycle and Inflammatory Arthritis by the Transcription Cofactor LBH Gene. J. Immunol. 199, 2316\u20132322 (2017)","journal-title":"J. Immunol."},{"key":"1228_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00439-018-1906-z","volume":"137","author":"Y Yamaguchi-Kabata","year":"2018","unstructured":"Y. Yamaguchi-Kabata, T. Morihara, T. Ohara, T. Ninomiya, A. Takahashi, H. Akatsu, Y. Hashizume, N. Hayashi, D. Shigemizu, K.A. Boroevich et al., Integrated analysis of human genetic association study and mouse transcriptome suggests LBH and SHF genes as novel susceptible genes for amyloid-beta accumulation in Alzheimer\u2019s disease. Hum. Genet. 137, 521\u2013533 (2018)","journal-title":"Hum. Genet."},{"key":"1228_CR11","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1016\/j.celrep.2015.11.040","volume":"13","author":"AT Vidakovic","year":"2015","unstructured":"A.T. Vidakovic, O.M. Rueda, S.J. Vervoort, A.S. Batra, M.A. Goldgraben, S. Uribe-Lewis, W. Greenwood, P.J. Coffer, A. Bruna, C. Caldas, Context-Specific Effects of TGF-\u03b2\/SMAD3 in Cancer Are Modulated by the Epigenome. Cell. Rep. 13, 2480\u20132490 (2015)","journal-title":"Cell. Rep."},{"key":"1228_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7150\/ijbs.66506","volume":"18","author":"A Wu","year":"2022","unstructured":"A. Wu, N. Luo, Y. Xu, N. Du, L. Li, Q. Liu, Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling. Int. J. Biol. Sci. 18, 242\u2013260 (2022)","journal-title":"Int. J. Biol. Sci."},{"key":"1228_CR13","doi-asserted-by":"publisher","first-page":"110045","DOI":"10.1016\/j.cellsig.2021.110045","volume":"85","author":"A Wu","year":"2021","unstructured":"A. Wu, L. Zhang, N. Luo, L. Zhang, L. Li, Q. Liu, Limb-bud and heart (LBH) inhibits cellular migration, invasion and epithelial-mesenchymal transition in nasopharyngeal carcinoma via downregulating \u03b1B-crystallin expression. Cell. Signal. 85, 110045 (2021)","journal-title":"Cell. Signal."},{"key":"1228_CR14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.7150\/jca.21375","volume":"9","author":"Q Liu","year":"2018","unstructured":"Q. Liu, E. Li, L. Huang, M. Cheng, L. Li, Limb-bud and Heart Overexpression Inhibits the Proliferation and Migration of PC3M Cells. J. Cancer. 9, 424\u2013432 (2018)","journal-title":"J. Cancer"},{"key":"1228_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000489801","volume":"47","author":"M Deng","year":"2018","unstructured":"M. Deng, R. Yu, S. Wang, Y. Zhang, Z. Li, H. Song, B. Liu, L. Xu, X. Wang, Z. Zhang et al., Limb-Bud and Heart Attenuates Growth and Invasion of Human Lung Adenocarcinoma Cells and Predicts Survival Outcome. Cell. Physiol. Biochem. 47, 223\u2013234 (2018)","journal-title":"Cell. Physiol. Biochem."},{"key":"1228_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ebiom.2019.09.037","volume":"48","author":"Y Jiang","year":"2019","unstructured":"Y. Jiang, J. Zhou, D. Zou, D. Hou, H. Zhang, J. Zhao, L. Li, J. Hu, Y. Zhang, Z. Jing, Overexpression of Limb-Bud and Heart (LBH) promotes angiogenesis in human glioma via VEGFA-mediated ERK signalling under hypoxia. EBioMedicine. 48, 36\u201348 (2019)","journal-title":"EBioMedicine"},{"key":"1228_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ebiom.2019.10.021","volume":"49","author":"KN Zhang","year":"2019","unstructured":"K.N. Zhang, F. Zeng, R.C. Chai, J. Chen, T. Jiang, Hypoxia induced LBH overexpression accelerates malignant progression in glioma. EBioMedicine. 49, 4\u20135 (2019)","journal-title":"EBioMedicine"},{"key":"1228_CR18","doi-asserted-by":"publisher","first-page":"e6885","DOI":"10.7717\/peerj.6885","volume":"7","author":"R Yu","year":"2019","unstructured":"R. Yu, Z. Li, C. Zhang, H. Song, M. Deng, L. Sun, L. Xu, X. Che, X. Hu, X. Qu et al., Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin\/FAK\/Akt pathway. PeerJ. 7, e6885 (2019)","journal-title":"PeerJ"},{"key":"1228_CR19","doi-asserted-by":"crossref","unstructured":"Garikapati K, Young I-C, Hong S, Rai P, Jain C, Briegel KJ. Briegel, Blocking LBH expression causes replication stress and sensitizes triple-negative breast cancer cells to ATR inhibitor treatment. Oncogene (2024)","DOI":"10.1038\/s41388-024-02951-3"},{"key":"1228_CR20","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1128\/MCB.01418-09","volume":"30","author":"ME Rieger","year":"2010","unstructured":"M.E. Rieger, A.H. Sims, E.R. Coats, R.B. Clarke, K.J. Briegel, The embryonic transcription cofactor LBH is a direct target of the Wnt signaling pathway in epithelial development and in aggressive basal subtype breast cancers. Mol. Cell. Biol. 30, 4267\u20134279 (2010)","journal-title":"Mol. Cell. Biol."},{"key":"1228_CR21","first-page":"893","volume":"142","author":"LE Lindley","year":"2015","unstructured":"L.E. Lindley, K.M. Curtis, A. Sanchez-Mejias, M.E. Rieger, D.J. Robbins, K.J. Briegel, The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage. Development. 142, 893\u2013904 (2015)","journal-title":"Development"},{"key":"1228_CR22","doi-asserted-by":"crossref","unstructured":"Tu S, Huang W, Huang C, Luo Z, Yan X. Contextual Regulation of TGF-\u03b2 Signaling in Liver Cancer. Cells 8, (2019)","DOI":"10.3390\/cells8101235"},{"key":"1228_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jgg.2020.09.005","volume":"47","author":"K Zhang","year":"2020","unstructured":"K. Zhang, M. Zhang, Z. Luo, Z. Wen, X. Yan, The dichotomous role of TGF-\u03b2 in controlling liver cancer cell survival and proliferation. J. Genet. Genomics. 47, 497\u2013512 (2020)","journal-title":"J. Genet. Genomics"},{"key":"1228_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"R. Derynck, S.J. Turley, R.J. Akhurst, TGF\u03b2 biology in cancer progression and immunotherapy. Nat. Reviews Clin. Oncol. 18, 9\u201334 (2021)","journal-title":"Nat. Reviews Clin. Oncol."},{"key":"1228_CR25","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massagu\u00e9","year":"2023","unstructured":"J. Massagu\u00e9, D. Sheppard, TGF-beta signaling in health and disease. Cell. 186, 4007\u20134037 (2023)","journal-title":"Cell"},{"key":"1228_CR26","doi-asserted-by":"publisher","first-page":"djt369","DOI":"10.1093\/jnci\/djt369","volume":"106","author":"DR Principe","year":"2014","unstructured":"D.R. Principe, J.A. Doll, J. Bauer, B. Jung, H.G. Munshi, L. Bartholin, B. Pasche, C. Lee, P.J. Grippo, TGF-\u03b2: duality of function between tumor prevention and carcinogenesis. J. Natl. Cancer Inst. 106, djt369 (2014)","journal-title":"J. Natl. Cancer Inst."},{"key":"1228_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Z. Deng, T. Fan, C. Xiao, H. Tian, Y. Zheng, C. Li, J. He, TGF-\u03b2 signaling in health, disease, and therapeutics. Signal. Transduct. Target. Ther. 9, 61 (2024)","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1228_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"D. Peng, M. Fu, M. Wang, Y. Wei, X. Wei, Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Mol. Cancer. 21, 104 (2022)","journal-title":"Mol. Cancer"},{"key":"1228_CR29","doi-asserted-by":"crossref","unstructured":"Liu SJ, Ren J, ten Dijke P. Targeting TGF\u03b2 signal transduction for cancer therapy. Signal. Transduct. Target. Therapy 6, (2021)","DOI":"10.1038\/s41392-020-00436-9"},{"key":"1228_CR30","doi-asserted-by":"crossref","unstructured":"Esfahanian N, Knoblich CD, Bowman GA, Rezvani K. Rezvani, Mortalin: Protein partners, biological impacts, pathological roles, and therapeutic opportunities. Front. Cell. Dev. Biology 11, (2023)","DOI":"10.3389\/fcell.2023.1028519"},{"key":"1228_CR31","doi-asserted-by":"crossref","unstructured":"Kaushal S, Gupta S, Shefrin S, Vora DS, Kaul SC, Sundar D, Wadhwa R, Dhanjal JK. Synthetic and Natural Inhibitors of Mortalin for Cancer Therapy. Cancers 16, (2024)","DOI":"10.3390\/cancers16203470"},{"key":"1228_CR32","doi-asserted-by":"publisher","first-page":"101042831769591","DOI":"10.1177\/1010428317695918","volume":"39","author":"J Sun","year":"2017","unstructured":"J. Sun, S.L. Che, J.J. Piao, M. Xu, L.Y. Chen, Z.H. Lin, Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer. Tumour Biol. 39, 1010428317695918 (2017)","journal-title":"Tumour Biol."},{"key":"1228_CR33","doi-asserted-by":"publisher","first-page":"104593","DOI":"10.1016\/j.yexmp.2020.104593","volume":"118","author":"R Zhang","year":"2021","unstructured":"R. Zhang, Z. Meng, X. Wu, M. Zhang, S. Zhang, T. Jin, Mortalin promotes breast cancer malignancy. Exp. Mol. Pathol. 118, 104593 (2021)","journal-title":"Exp. Mol. Pathol."},{"key":"1228_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/s13046-019-1500-9","volume":"38","author":"JF Putri","year":"2019","unstructured":"J.F. Putri, P. Bhargava, J.K. Dhanjal, T. Yaguchi, D. Sundar, S.C. Kaul, R. Wadhwa, Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers. J. Exp. Clin. Cancer Res. 38, 499 (2019)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1228_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41420-021-00517-w","volume":"7","author":"Y Dai","year":"2021","unstructured":"Y. Dai, F. Li, Y. Jiao, G. Wang, T. Zhan, Y. Xia, H. Liu, H. Yang, J. Zhang, L. Tang, Mortalin\/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation\/apoptosis and metabolic reprogramming. Cell. Death Discov. 7, 140 (2021)","journal-title":"Cell. Death Discov"},{"key":"1228_CR36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ijc.28029","volume":"133","author":"P Rozenberg","year":"2013","unstructured":"P. Rozenberg, J. Kocsis, M. Saar, Z. Proh\u00e1szka, G. F\u00fcst, Z. Fishelson, Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer. Int. J. Cancer. 133, 514\u2013518 (2013)","journal-title":"Int. J. Cancer"},{"key":"1228_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/path.1672","volume":"205","author":"SR Dundas","year":"2005","unstructured":"S.R. Dundas, L.C. Lawrie, P.H. Rooney, G.I. Murray, Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J. Pathol. 205, 74\u201381 (2005)","journal-title":"J. Pathol."},{"key":"1228_CR38","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/ijc.25857","volume":"129","author":"WJ Lu","year":"2011","unstructured":"W.J. Lu, N.P. Lee, S.C. Kaul, F. Lan, R.T. Poon, R. Wadhwa, J.M. Luk, Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. Int. J. Cancer. 129, 1806\u20131814 (2011)","journal-title":"Int. J. Cancer"},{"key":"1228_CR39","doi-asserted-by":"publisher","first-page":"39373","DOI":"10.1074\/jbc.M500022200","volume":"280","author":"SC Kaul","year":"2005","unstructured":"S.C. Kaul, S. Aida, T. Yaguchi, K. Kaur, R. Wadhwa, Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides. J. Biol. Chem. 280, 39373\u201339379 (2005)","journal-title":"J. Biol. Chem."},{"key":"1228_CR40","doi-asserted-by":"publisher","first-page":"879632","DOI":"10.3389\/fcell.2022.879632","volume":"10","author":"A Elwakeel","year":"2022","unstructured":"A. Elwakeel, Abrogating the Interaction Between p53 and Mortalin (Grp75\/HSPA9\/mtHsp70) for Cancer Therapy: The Story so far. Front. Cell. Dev. Biol. 10, 879632 (2022)","journal-title":"Front. Cell. Dev. Biol."},{"key":"1228_CR41","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/jcmm.12905","volume":"20","author":"Y Hu","year":"2016","unstructured":"Y. Hu, L. Yang, Y. Yang, Y. Han, Y. Wang, W. Liu, J. Zuo, Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK-ERK pathway. J. Cell. Mol. Med. 20, 2111\u20132121 (2016)","journal-title":"J. Cell. Mol. Med."},{"key":"1228_CR42","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jmb.2011.09.009","volume":"414","author":"L Yang","year":"2011","unstructured":"L. Yang, W. Guo, Q. Zhang, H. Li, X. Liu, Y. Yang, J. Zuo, W. Liu, Crosstalk between Raf\/MEK\/ERK and PI3K\/AKT in suppression of Bax conformational change by Grp75 under glucose deprivation conditions. J. Mol. Biol. 414, 654\u2013666 (2011)","journal-title":"J. Mol. Biol."},{"key":"1228_CR43","first-page":"2696","volume":"11","author":"B Wei","year":"2021","unstructured":"B. Wei, J. Cao, J.H. Tian, C.Y. Yu, Q. Huang, J.J. Yu, R. Ma, J. Wang, F. Xu, L.B. Wang, Mortalin maintains breast cancer stem cells stemness via activation of Wnt\/GSK3\u03b2\/\u03b2-catenin signaling pathway. Am. J. Cancer Res. 11, 2696\u20132716 (2021)","journal-title":"Am. J. Cancer Res."},{"key":"1228_CR44","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1158\/0008-5472.CAN-15-2704","volume":"76","author":"Y Na","year":"2016","unstructured":"Y. Na, S.C. Kaul, J. Ryu, J.S. Lee, H.M. Ahn, Z. Kaul, R.S. Kalra, L. Li, N. Widodo, C.O. Yun, R. Wadhwa, Stress chaperone mortalin contributes to epithelial-mesenchymal transition and cancer metastasis. Cancer Res. 76, 2754\u20132765 (2016)","journal-title":"Cancer Res."},{"key":"1228_CR45","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.7150\/ijbs.98772","volume":"20","author":"J Wu","year":"2024","unstructured":"J. Wu, M. Huang, W. Dong, Y. Chen, Q. Zhou, Q. Zhang, J. Zheng, Y. Liu, Y. Zhang, S. Liu et al., SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation. Int. J. Biol. Sci. 20, 3986\u20134006 (2024)","journal-title":"Int. J. Biol. Sci."},{"key":"1228_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3892\/ijo.2013.2161","volume":"44","author":"J Chen","year":"2014","unstructured":"J. Chen, W.B. Liu, W.D. Jia, G.L. Xu, J.L. Ma, M. Huang, Y.R. Deng, J.S. Li, Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition. Int. J. Oncol. 44, 247\u2013255 (2014)","journal-title":"Int. J. Oncol."},{"key":"1228_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1074\/mcp.M700116-MCP200","volume":"7","author":"X Yi","year":"2008","unstructured":"X. Yi, J.M. Luk, N.P. Lee, J. Peng, X. Leng, X.Y. Guan, G.K. Lau, L. Beretta, S.T. Fan, Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol. Cell. Proteom. 7, 315\u2013325 (2008)","journal-title":"Mol. Cell. Proteom."},{"key":"1228_CR48","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12935-021-02367-z","volume":"21","author":"M Teng","year":"2021","unstructured":"M. Teng, C. Hu, B. Yang, W. Xiao, Q. Zhou, Y. Li, Z. Li, Salvianolic acid B targets mortalin and inhibits the migration and invasion of hepatocellular carcinoma via the RECK\/STAT3 pathway. Cancer Cell. Int. 21, 654 (2021)","journal-title":"Cancer Cell. Int."},{"key":"1228_CR49","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-024-07054-3","volume":"627","author":"L Chen","year":"2024","unstructured":"L. Chen, C. Zhang, R. Xue, M. Liu, J. Bai, J. Bao, Y. Wang, N. Jiang, Z. Li, W. Wang et al., Deep whole-genome analysis of 494 hepatocellular carcinomas. Nature. 627, 586\u2013593 (2024)","journal-title":"Nature"},{"key":"1228_CR50","doi-asserted-by":"publisher","first-page":"107208","DOI":"10.1016\/j.jbc.2024.107208","volume":"300","author":"C Zhang","year":"2024","unstructured":"C. Zhang, W. Wei, S. Tu, B. Liang, C. Li, Y. Li, W. Luo, Y. Wu, X. Dai, Y. Wang et al., Upregulation of CYR61 by TGF-\u03b2 and YAP signaling exerts a counter-suppression of hepatocellular carcinoma. J. Biol. Chem. 300, 107208 (2024)","journal-title":"J. Biol. Chem."},{"key":"1228_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/jmcb\/mjx042","volume":"10","author":"X Yan","year":"2018","unstructured":"X. Yan, J. Wu, Q. Jiang, H. Cheng, J.J. Han, Y.G. Chen, CXXC5 suppresses hepatocellular carcinoma by promoting TGF-beta-induced cell cycle arrest and apoptosis. J. Mol. Cell. Biol. 10, 48\u201359 (2018)","journal-title":"J. Mol. Cell. Biol."},{"key":"1228_CR52","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s13577-023-00889-4","volume":"36","author":"W Dai","year":"2023","unstructured":"W. Dai, Y. Guo, Z. Shen, J. Wang, L. Lu, H. Dong, X. Cai, Identification of LBH and SPP1 involved in hepatic stellate cell activation during liver fibrogenesis. Hum. Cell. 36, 1054\u20131067 (2023)","journal-title":"Hum. Cell"},{"key":"1228_CR53","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/art.39060","volume":"67","author":"AK Ekwall","year":"2015","unstructured":"A.K. Ekwall, J.W. Whitaker, D. Hammaker, W.D. Bugbee, W. Wang, G.S. Firestein, The Rheumatoid Arthritis Risk Gene LBH Regulates Growth in Fibroblast-like Synoviocytes. Arthritis Rheumatol. 67, 1193\u20131202 (2015)","journal-title":"Arthritis Rheumatol."},{"key":"1228_CR54","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.3892\/ol.2020.11778","volume":"20","author":"SS Wu","year":"2020","unstructured":"S.S. Wu, J. Chen, Y. Yan, H.Q. Luo, W.J. Chen, Y.F. He, Limb-bud and heart as a novel biomarker for gastric intestinal type adenocarcinoma. Oncol. Lett. 20, 2209\u20132216 (2020)","journal-title":"Oncol. Lett."},{"key":"1228_CR55","doi-asserted-by":"crossref","unstructured":"Zhang GQ, Jiang Y, Wang ZC, Guo ZT, Hu JP, Li XQ, Wang YF, Jing ZT. FUS\/circZEB1\/miR-128-3p\/LBH feedback loop contributes to the malignant phenotype of GSCs via TNF-\u03b1-mediated NF-\u03baB signaling pathway. Cancer. Cell. Int. 24, (2024)","DOI":"10.1186\/s12935-024-03526-8"},{"key":"1228_CR56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","volume":"15","author":"X Shi","year":"2022","unstructured":"X. Shi, J. Yang, S. Deng, H. Xu, D. Wu, Q. Zeng, S. Wang, T. Hu, F. Wu, H. Zhou, TGF-\u03b2 signaling in the tumor metabolic microenvironment and targeted therapies. J. Hematol. Oncol. 15, 135 (2022)","journal-title":"J. Hematol. Oncol."},{"key":"1228_CR57","doi-asserted-by":"crossref","unstructured":"Xu Y, Wu A, Chen J, Song X, Chen M, Liu Q. Limb-Bud and Heart (LBH) Upregulation in Cardiomyocytes under Hypoxia Promotes the Activation of Cardiac Fibroblasts via Exosome Secretion. Mediators of Inflammation. 2022,8939449 (2022)","DOI":"10.1155\/2022\/8939449"},{"key":"1228_CR58","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1242\/jcs.195339","volume":"130","author":"I Mylonis","year":"2017","unstructured":"I. Mylonis, M. Kourti, M. Samiotaki, G. Panayotou, G. Simos, Mortalin-mediated and ERK-controlled targeting of HIF-1\u03b1 to mitochondria confers resistance to apoptosis under hypoxia. J. Cell. Sci. 130, 466\u2013479 (2017)","journal-title":"J. Cell. Sci."},{"key":"1228_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13046-016-0316-0","volume":"35","author":"H Jin","year":"2016","unstructured":"H. Jin, M. Ji, L. Chen, Q. Liu, S. Che, M. Xu, Z. Lin, The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast. J. Exp. Clin. Cancer Res. 35, 42 (2016)","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01228-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01228-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01228-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T01:05:44Z","timestamp":1786064744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01228-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01228-z","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experimental protocol was approved by the Institutional Animal Care and Use Committee of Nanchang University (Ethics Approval No. NCULAE-20250912003). All procedures were conducted in strict accordance with the relevant institutional guidelines and regulations.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}